PSTV: PLUS THERAPEUTICS, Inc. Common Stock Company Profile & Statistics

PLUS THERAPEUTICS, Inc. Common Stock Profile

About

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.

Info & Links

CEO

Marc. H. Hedrick

Headquarters

2710 REED ROAD, SUITE 160
HOUSTON, TX 77051, UNITED STATES

Auditor

BDO USA P.C.

Share holders

Employees

PLUS THERAPEUTICS, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

53.11M

Enterprise Value

50.87M

Enterprise Value/EBITDA(ttm)

-4.19

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

10.01

Price to Book(mrq)

16.10

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-217.44%

Profit Margin(ttm)

-436.60%

Return on Equity(ttm)

Return on Invested Capital(ttm)

342.54%

Return on Assets(ttm)

-118.11%

Income Statement

Revenue(ttm)

5.32M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

5.32M

EBITDA(ttm)³

-12.15M

Net Income Available to Common(ttm)

-19.03M

Diluted EPS(ttm)

-1.91

Share Statistics

Beta (5Y Monthly)

0.81

52-Week Change

-59.55%

S&P 500 52-Week Change

19.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

99.26M

Dividend Yield

0.00%

Float⁴

98.48M

% Held by Insiders

0.79%

% Held by Institutions

3.28%

Balance Sheet

Total Cash(mrq)

6.88M

Total Cash Per Share(mrq)

0.07

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.26%

Quick Ratio(mrq)

1.26%

Book Value Per Share(mrq)

0.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.06

Free Cash Flow(ytd)

-11.95M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PSTV

PLUS THERAPEUTICS, Inc. Common Stock